aspirin and eptifibatide

aspirin has been researched along with eptifibatide in 95 studies

Research

Studies (95)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	14 (14.74)	18.2507
2000's	57 (60.00)	29.6817
2010's	19 (20.00)	24.3611
2020's	5 (5.26)	2.80

Authors

Authors	Studies
Lombardo, F; Obach, RS; Waters, NJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Gui, L; Li, Z; Peng, S; Wang, X; Wang, Y; Wu, J; Zhang, X; Zhao, M; Zhao, S; Zheng, M	1
Harrington, RA; Joseph, D; Kleiman, NS; Kottke-Marchant, K; Lincoff, AM; Rios, G; Rose, D; Sigmon, KN; Tcheng, JE; Trainor, K	1
Talley, JD	1
Anderson, HV; Bahr, RD; Brashears, L; Bray, PF; Califf, RM; Chandra, NC; du Mee, C; Effron, MB; Fatterpacker, A; Ferguson, JJ; Gerstenblith, G; Goldschmidt-Clermont, PJ; Gottdiener, P; Guerci, AD; Harrington, RA; Kitt, MM; Lincoff, AM; Mason, SJ; Navetta, FI; Nygaard, TW; Raskin, S; Schulman, SP; Smith, J; Topol, EJ; Willerson, JT; Wolfe, CL; Yakubov, SJ; Yock, PG	1
Baughman, KL; Bray, PF; Chandra, NC; Coleman, LD; Dise, KR; Dorsey, FC; du Mee, C; Fox, RJ; Gerstenblith, G; Goldschmidt-Clermont, PJ; Grigoryev, D; Kitt, MM; Ouyang, P; Richardson, C; Sagar, M; Schulman, SP	1
Piazza, V; Rulli, F	1
Segal, J	1
Alexander, JH; Armstrong, PW; Berdan, LG; Boland, JB; Califf, RM; Deckers, JW; Eisenberg, PR; Guerci, A; Harrington, RA; Hochman, JS; Karsh, K; Kitt, MM; Lincoff, AM; Ruzyllo, W; Simoons, ML; Stepinska, J; Topol, EJ; Tuttle, RH; Widimsky, P; Wilcox, RG	1
Alberts, MJ; Berdan, LG; Califf, RM; Deckers, J; Graffagnino, C; Granger, CB; Harrington, RA; Laskowitz, DT; Lincoff, AM; MacAulay, CM; Mahaffey, KW; Miller, JM; Simoons, ML; Sloan, MA; Topol, EJ	1
Al-Mousa, EN; Arshad, MN; Campsey, M; Gandhi, R; Gibson, CM; Marble, SJ; Mattson, S; Mesley, R; Moynihan, JL; Murphy, S; Ryan, KA; Swanson, J	1
Kaluza, G; Kleiman, NS; Mazur, W	1
Harrington, RA	1
Juran, NB	1
Wilcox, R	1
Altmann, E; Cuffie-Jackson, CA; Molhoek, PG; Neuhaus, KL; Ronner, E; Simoons, ML; van der Wieken, LR; van Kesteren, HA; Zijnen, P	1
Agustí, A; Araujo, R	1
Bassand, JP	1
Butenas, S; Cawthern, KM; DiLorenzo, ME; Lock, JB; Mann, KG; van't Veer, C	1
Schrör, K	1
Nurden, P	1
Birnbaum, Y; Golovchiner, G; Iakobishvili, Z; Matz, I; Siegel, RJ; Vaturi, M; Wyshelesky, A	1
Bertolet, BD; Gupta, A; Miller, L	1
Berkowitz, SD; Christie, DJ; Madan, M; Sigmon, KN; Smit, AC; Tcheng, JE	1
Ball, SA; Dauerman, HL; Desourdy, MA; Furman, MI; Goldberg, RJ	1
Bottorff, MB; Nappi, JM; Spinler, SA; Talbert, RL	1
Barbera, FA; Dorsam, RT; Feuerstein, GZ; Friedman, SM; Gibbs, S; Lauver, A; Savion, N; Varon, D; Wang, H; Wang, X	1
Armstrong, PW; Fitchett, D; Goodman, SG; Langer, A; Tan, M	1
Alves, VL; Nannizzi-Alaimo, L; Phillips, DR	1
Tsakiris, DA	1
Lecompte, T	1
Goto, S	1
Blazicek, H; Domanovits, H; Galehr, E; Jilma, B; Jilma-Stohlawetz, P; Mayr, F; Reiter, RA	1
André, P; Conley, PB; Delaney, SM; LaRocca, T; Lin, PH; Phillips, DR; Sinha, U; Vincent, D	1
Harrington, RA; Hochman, JS; Houghtaling, PL; Jaber, WA; Marso, SP; Menon, V; Prior, DL; Simoons, ML; Srichai, MB	1
Bal dit Sollier, C; Choussat, R; Collet, JP; Dalby, M; Drobinski, G; Drouet, L; Gallois, V; Montalescot, G; Soulat, T; Thomas, D; Vicaut, E	1
Atar, S; Birnbaum, Y; Chen, M; Kobal, S; Luo, H; Miyamoto, T; Neuman, Y; Siegel, RJ	1
Chen, Z; Ehlers, R; Nannizzi-Alaimo, L; Phillips, DR; Rogers, SD; Simon, DI; Welt, FG; Zhang, X	1
Bolton, ED; Braunstein, JB; Chiles, KA; Faraday, N; Gerstenblith, G; Heldman, AW; Schulman, SP	1
Hirmerova, J; Moll, S; Napoli, M; Ohman, EM; Rubery, B; Simpson, R; Stouffer, GA	1
Haerten, K; Krabbe, C; Raiber, M	1
Beinart, R; Bienart, R; Goldenberg, I; Guetta, V; Hod, H; Matetzky, S; Novikov, I; Pres, H; Savion, N; Shechter, M; Shenkman, B; Varon, D	1
Antman, EM; Wiviott, SD	1
Braunwald, E; Califf, RM; Cholera, S; Gibson, CM; Giugliano, RP; Harrington, RA; Jennings, LK; Krishnan, R; Lorenz, DP; Murphy, SA	1
Frimerman, A; Lev-Ran, O; Locker, C; Mohr, R; Shaham, Y; Shapira, I; Uretzky, G	1
Domanovits, H; Frossard, M; Fuchs, I; Hsieh, K; Jilma, B; Laggner, AN; Leitner, JM; Losert, H; Schreiber, W; Vlcek, M	1
Schulman, SP	1
Colombo, A; Danna, P; Piccaluga, E; Viecca, M	1
Davis, KE; Denardo, SJ; Tcheng, JE	1
Horvath, M; Jilma, B; Jilma-Stohlawetz, P; Reiter, R	1
Antman, EM; Leopold, JA	1
Graff, J; Harder, S	1
Bhatt, DL; Duffy, B	1
Armstrong, PW; Fitchett, DH; Goodman, SG; Langer, A; Mendelsohn, A; Tan, M	1
Kecskés, M; Losonczy, H; Nagy, A; Pótó, L; Szabó, C; Tóth, O	1
Jennings, LK	1
Radke, PW; Schunkert, H	1
Abraham, J; Jones, PA; Kramer, J; Teven, CM	1
Fontana, P	1
Banares, M; Gollapudi, RR; Lee, SS; Price, MJ; Sawhney, N; Schatz, RA; Teirstein, PS; Valencia, R; Wong, GB	1
Kwa, AT; Rogers, JH	1
Boden, WE; Hoekstra, J; Miller, CD	1
Buerke, M; Carter, JM; Hauroeder, B; Maegdefessel, L; Michel, T; Peetz, D; Reindl, I; Schlitt, A; Schubert, S; Werdan, K	1
Gurbel, PA; Tantry, US	1
Kereiakes, DJ	1
Aymong, E; Buller, CE; Carere, RG; Densem, C; Fox, RS; Fung, AY; Hamburger, JN; Humphries, KH; Jokhi, P; Ricci, DR; Saw, J; Starovoytov, A; Walsh, SJ; Webb, JG	1
Caraccciolo, EA; Chrissoheris, M; Ionescu, CN	1
Buller, C; Densem, C; Fox, R; Fung, A; Jokhi, P; Mancini, GB; Ricci, D; Saw, J; Starovoytov, A; Walsh, S; Wong, G	1
Chandler, AB; Earhart, AD; Hansen, J; Jennings, LK; Kueter, TJ; Speich, HE; White, MM	1
Bergman, G; Feldman, DN; Minutello, RM; Wong, SC	1
Froeschl, M; Glover, CA; Jadhav, S; Kass, M; Labinaz, M; Le May, MR; Marquis, JF; O'Brien, ER; So, DY; Thomas, A; Turek, M; Wells, GA	1
Ackman, ML; Pickett, AM; Taylor, DA	1
Erdem, G; Flather, MD; Geisler, T	1
Matthai, WH; Patel, PJ; Untereker, WJ	1
Burstein, S; Perez, E; Yang, EH; Zhiroff, KA	1
Rayoo, R; Sharma, N; van Gaal, WJ	1
Buerke, M; Mannes, F; Plehn, A; Schlitt, A; Vogt, A; Werdan, K; Wolf, HH	1
Bauer, ME; Bauer, ST; Mhyre, JM; Rabbani, AB	1
Blackstone, E; Cavender, MA; Cho, L; Ellis, SG; Militello, MA; Rassi, AN; Sun, Z; Theodos, G	1
Berg, R; Bolla, VH; Singh, M	1
Adataya, S; Adatya, S; Eckman, P; John, R; Masri, C	1
Angiolillo, DJ; Antonelli, M; Biglioli, F; Boni, L; Bovenzi, F; Bozzani, A; Bramucci, E; Buffoli, F; Capodanno, D; Castiglioni, B; Comel, A; Cremonesi, A; Crescini, C; D'Angelo, F; De Servi, S; Dionigi, G; Droghetti, A; Francetti, L; Gadda, F; Guagliumi, G; Lettieri, C; Lettino, M; Lorini, L; Musumeci, G; Parolari, A; Piccaluga, E; Ravelli, P; Rossini, R; Salvi, L; Savonitto, S; Scarone, P; Setacci, C; Staurenghi, G; Trabattoni, D; Valdatta, L; Visconti, LO	1
Anderson, JL; Bates, ER; Bode, C; Granger, CB; Huber, K; Kristensen, SD; Lopez Sendon, JL; Ohman, EM; Steg, PG; Tubaro, M; Valgimigli, M; Wallentin, L	1
Bainey, KR; Ferguson, C; Sharma, A	1
Bochenek, A; Buldak, Ł; Buszman, P; Kondys, M; Milewski, K; Sanak, M; Wilczynski, M; Wita, K; Wybraniec, MT	1
Bansilal, S; Becker, RC; Cannon, CP; Harrington, RA; Himmelmann, A; Husted, S; James, SK; Katus, HA; Lopes, RD; Neely, B; Shimada, YJ; Steg, PG; Storey, RF; Wallentin, L; Wiviott, SD	1
Banerjee, S; Baskar, A; Chauhan, S; Cui, Z; Dargham, BB; Sum-Ping, J; Tejani, I; Weideman, RA	1
Curtis, BR; Erdil, RM; Gilyard, SN; Knelson, EH; Leaf, RK; Malhotra, R; Puram, RV; Ranganathan, R; Van Beuningen, AM; Wallwork, R; Weber, BN	1
Biederko, R; Borodetsky, V; Horev, A; Ifergane, G; Shelef, I; Star, M; Zlotnik, Y; Zvenigorodsky, V	1
Bazrafshan, A; Duan, Y; Glazier, R; Hu, Y; Ke, Y; Petrich, BG; Rashid, SA; Salaita, K	1
Al Kindi, DI; Al-Mashdali, A; Alamin, MA; Elshaikh, EA; Othman, F	1
Deng, Y; Fei, X; Goda, K; Hou, HW; Nishikawa, M; Tang, X; Tay, HM; Xiao, TH; Yatomi, Y; Zhou, Y	1

Reviews

23 review(s) available for aspirin and eptifibatide

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Glycoprotein IIb/IIIa receptor inhibition in interventional cardiology. Journal of thrombosis and thrombolysis, 1999, Volume: 7, Issue:3 Topics: Abciximab; Administration, Oral; Adult; Aged; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Aspirin; Cardiology; Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Embolism; Eptifibatide; Female; Fibrinolytic Agents; Follow-Up Studies; Forecasting; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Male; Meta-Analysis as Topic; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Peptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prospective Studies; Risk; Stents; Structure-Activity Relationship; Tirofiban; Treatment Outcome; Tyrosine	1999
Antiplatelet therapy for treatment of acute coronary syndromes. Cardiology clinics, 1999, Volume: 17, Issue:2 Topics: Abciximab; Acetates; Antibodies, Monoclonal; Aspirin; Clopidogrel; Coronary Disease; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Peptides; Platelet Aggregation Inhibitors; Ticlopidine; Tirofiban; Treatment Outcome; Tyrosine; Vascular Patency	1999
Overview of clinical trials of glycoprotein IIb-IIIa inhibitors in acute coronary syndromes. American heart journal, 1999, Volume: 138, Issue:4 Pt 2 Topics: Acute Disease; Anticoagulants; Aspirin; Clinical Trials as Topic; Coronary Disease; Coronary Thrombosis; Eptifibatide; Fibrinolytic Agents; Heparin; Humans; Myocardial Ischemia; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Tirofiban; Tyrosine	1999
Minimizing bleeding complications of percutaneous coronary intervention and glycoprotein IIb-IIIa antiplatelet therapy. American heart journal, 1999, Volume: 138, Issue:4 Pt 2 Topics: Abciximab; Antibodies, Monoclonal; Anticoagulants; Aspirin; Catheterization, Peripheral; Coronary Disease; Coronary Thrombosis; Eptifibatide; Femoral Artery; Fibrinolytic Agents; Hemorrhage; Heparin; Humans; Immunoglobulin Fab Fragments; Myocardial Revascularization; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Tirofiban; Tyrosine	1999
Patency, perfusion, performance--the desirable triplets of combination thrombolytic therapy. European heart journal, 2000, Volume: 21, Issue:18 Topics: Aspirin; Coronary Circulation; Drug Therapy, Combination; Eptifibatide; Fibrinolytic Agents; Humans; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Streptokinase; Thrombolytic Therapy; Vascular Patency	2000
Low-molecular-weight heparin and other antithrombotic agents in the setting of a fast-track revascularization in unstable coronary artery disease. Haemostasis, 2000, Volume: 30 Suppl 2 Topics: Abciximab; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Aspirin; Clinical Trials as Topic; Combined Modality Therapy; Diabetes Complications; Drug Therapy, Combination; Eptifibatide; Factor Xa Inhibitors; Heparin, Low-Molecular-Weight; Hirudin Therapy; Hirudins; Humans; Immunoglobulin Fab Fragments; Myocardial Revascularization; Oligosaccharides; Peptide Fragments; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Postoperative Complications; Randomized Controlled Trials as Topic; Recombinant Proteins; Risk Factors; Thrombocytopenia; Thrombosis; Time Factors; Tirofiban; Treatment Outcome; Tyrosine	2000
[GPIIb-IIIa inhibitors]. Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine, 2001, Volume: 8, Issue:2 Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Aspirin; Coronary Disease; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Tirofiban; Tyrosine	2001
Combination antiplatelet therapy: implications for pharmacists. Pharmacotherapy, 2002, Volume: 22, Issue:10 Topics: Adult; Aspirin; Clopidogrel; Coronary Restenosis; Drug Therapy, Combination; Eptifibatide; Female; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Patient Compliance; Peptides; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Stents; Ticlopidine	2002
[Platelet inhibitors: old and new]. La Tunisie medicale, 2002, Volume: 80, Issue:8 Suppl Topics: Abciximab; Antibodies, Monoclonal; Arteriosclerosis; Aspirin; Clopidogrel; Coronary Disease; Dipyridamole; Drug Monitoring; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Membrane Proteins; Patient Selection; Peptides; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Thrombosis; Thromboxanes; Ticlopidine	2002
[GP IIb/IIIa receptor prevention medicine]. Nihon rinsho. Japanese journal of clinical medicine, 2003, Volume: 61 Suppl 4 Topics: Abciximab; Animals; Antibodies, Monoclonal; Aspirin; Clinical Trials as Topic; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombolytic Therapy; Tirofiban; Tyrosine	2003
Comparison of bilateral thoracic artery grafting with percutaneous coronary interventions in diabetic patients. The Annals of thoracic surgery, 2004, Volume: 78, Issue:2 Topics: Abciximab; Aged; Angioplasty, Balloon; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Aspirin; Combined Modality Therapy; Coronary Artery Bypass; Coronary Disease; Diabetes Complications; Diltiazem; Eptifibatide; Female; Humans; Immunoglobulin Fab Fragments; Isosorbide Dinitrate; Life Tables; Male; Middle Aged; Peptides; Platelet Aggregation Inhibitors; Recurrence; Retrospective Studies; Stents; Survival Analysis; Thoracic Arteries; Ticlopidine; Treatment Outcome; Vascular Patency	2004
Antiplatelet agents in patients undergoing percutaneous coronary intervention: how many and how much? American journal of cardiovascular drugs : drugs, devices, and other interventions, 2005, Volume: 5, Issue:5 Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Aspirin; Clinical Trials as Topic; Clopidogrel; Eptifibatide; Hirudins; Humans; Immunoglobulin Fab Fragments; Peptide Fragments; Peptides; Platelet Aggregation Inhibitors; Recombinant Proteins; Ticlopidine; Tirofiban; Tyrosine	2005
Current strategies with eptifibatide and other antiplatelet agents in percutaneous coronary intervention and acute coronary syndromes. Expert opinion on drug metabolism & toxicology, 2005, Volume: 1, Issue:4 Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Aspirin; Coronary Disease; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Tirofiban; Tyrosine	2005
[Antithrombotic treatment of acute coronary syndromes without ST-segment elevation]. Deutsche medizinische Wochenschrift (1946), 2006, Nov-24, Volume: 131, Issue:47 Suppl 7 Topics: Abciximab; Antibodies, Monoclonal; Aspirin; Clopidogrel; Eptifibatide; Fibrinolytic Agents; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Risk Factors; Syndrome; Ticlopidine; Tirofiban; Tyrosine	2006
[Update on antithrombotic treatments in arterial diseases]. Revue medicale suisse, 2007, Feb-07, Volume: 3, Issue:97 Topics: Abciximab; Antibodies, Monoclonal; Anticoagulants; Arteriosclerosis; Aspirin; Dipyridamole; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Peptides; Platelet Aggregation Inhibitors; Pyridines; Thrombosis; Tirofiban; Treatment Outcome; Tyrosine	2007
Current update on glycoprotein IIb-IIIa and direct thrombin inhibition in percutaneous coronary intervention for non-ST elevation acute coronary syndromes: balancing bleeding risk and antiplatelet efficacy. Journal of interventional cardiology, 2008, Volume: 21, Issue:2 Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Antithrombins; Aspirin; Clopidogrel; Enoxaparin; Eptifibatide; Fibrinolytic Agents; Heart Conduction System; Hemorrhage; Heparin; Hirudins; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Peptide Fragments; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Recombinant Proteins; Risk Assessment; Risk Factors; Ticlopidine	2008
ST-elevation myocardial infarction: the role of adjunctive antiplatelet therapy. The American journal of emergency medicine, 2008, Volume: 26, Issue:2 Topics: Abciximab; Antibodies, Monoclonal; Aspirin; Clopidogrel; Electrocardiography; Eptifibatide; Fibrinolytic Agents; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyridines; Ticlopidine; Tirofiban; Tyrosine	2008
The rationale for and comparisons of different antiplatelet treatments in acute coronary syndrome. Journal of interventional cardiology, 2008, Volume: 21 Suppl 1 Topics: Acute Coronary Syndrome; Aspirin; Blood Coagulation; Blood Platelets; Clopidogrel; Drug Therapy, Combination; Eptifibatide; Humans; Ischemia; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Risk Factors; Ticlopidine; Treatment Outcome	2008
Prolonged infusion of eptifibatide as bridge therapy between bare-metal stent insertion and cardiovascular surgery: case report and review of the literature. Pharmacotherapy, 2010, Volume: 30, Issue:4 Topics: Angioplasty; Anticoagulants; Aspirin; Cardiovascular Surgical Procedures; Clopidogrel; Coronary Artery Bypass; Eptifibatide; Hemorrhage; Humans; Male; Metals; Middle Aged; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Stents; Thrombosis; Ticlopidine	2010
What goes into a major acute coronary syndrome trial and what will future trials look like? Current cardiology reports, 2010, Volume: 12, Issue:4 Topics: Acute Coronary Syndrome; Adenosine; Aspirin; Clinical Trials as Topic; Clopidogrel; Cyclic N-Oxides; Eptifibatide; Heart Diseases; Humans; Peptides; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Pyridines; Research Design; Research Support as Topic; Risk Factors; Sample Size; Thiophenes; Ticagrelor; Ticlopidine; United Kingdom	2010
Antiplatelet and anticoagulation agents in acute coronary syndromes: what is the current status and what does the future hold? American heart journal, 2014, Volume: 168, Issue:5 Topics: Acute Coronary Syndrome; Adenosine; Adenosine Monophosphate; Anticoagulants; Aspirin; Drug Therapy, Combination; Enoxaparin; Eptifibatide; Fondaparinux; Heparin; Hirudins; Humans; Lactones; Peptide Fragments; Peptides; Piperazines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Polysaccharides; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Pyridines; Receptors, Thrombin; Recombinant Proteins; Thiophenes; Ticagrelor; Tirofiban; Tyrosine; Warfarin	2014
Thrombocytopenia in acute coronary syndromes: etiologies and proposed management. The Canadian journal of cardiology, 2015, Volume: 31, Issue:6 Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Drug Therapy, Combination; Electrocardiography; Enzyme-Linked Immunosorbent Assay; Eptifibatide; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Count; Platelet Transfusion; Risk Assessment; Thrombocytopenia; Ticlopidine; Treatment Outcome	2015

Trials

25 trial(s) available for aspirin and eptifibatide

Article	Year
Immediate and reversible platelet inhibition after intravenous administration of a peptide glycoprotein IIb/IIIa inhibitor during percutaneous coronary intervention. The American journal of cardiology, 1995, Dec-15, Volume: 76, Issue:17 Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Coronary Disease; Double-Blind Method; Eptifibatide; Female; Heparin; Humans; Male; Middle Aged; Peptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Prospective Studies; Single-Blind Method; Treatment Outcome	1995
Effects of integrelin, a platelet glycoprotein IIb/IIIa receptor antagonist, in unstable angina. A randomized multicenter trial. Circulation, 1996, Nov-01, Volume: 94, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Angina, Unstable; Anticoagulants; Aspirin; Bleeding Time; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography, Ambulatory; Eptifibatide; Female; Hemorrhage; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Peptides; Placebos; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prospective Studies; Sex Factors; Substance Withdrawal Syndrome	1996
Refining the treatment of women with unstable angina--a randomized, double-blind, comparative safety and efficacy evaluation of Integrelin versus aspirin in the management of unstable angina. Clinical cardiology, 1996, Volume: 19, Issue:11 Topics: Aged; Aged, 80 and over; Angina, Unstable; Aspirin; Double-Blind Method; Electrocardiography, Ambulatory; Eptifibatide; Female; Humans; Male; Peptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Retrospective Studies; Safety; Sex Factors	1996
Randomised placebo-controlled trial of effect of eptifibatide on complications of percutaneous coronary intervention: IMPACT-II. Integrilin to Minimise Platelet Aggregation and Coronary Thrombosis-II. Lancet (London, England), 1997, May-17, Volume: 349, Issue:9063 Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Atherectomy, Coronary; Coronary Disease; Eptifibatide; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Ischemia; Myocardial Revascularization; Peptides; Platelet Aggregation Inhibitors; Risk; Treatment Outcome	1997
Prior aspirin use predicts worse outcomes in patients with non-ST-elevation acute coronary syndromes. PURSUIT Investigators. Platelet IIb/IIIa in Unstable angina: Receptor Suppression Using Integrilin Therapy. The American journal of cardiology, 1999, Apr-15, Volume: 83, Issue:8 Topics: Acute Disease; Aged; Angina, Unstable; Aspirin; Electrocardiography; Eptifibatide; Female; Follow-Up Studies; Humans; Male; Middle Aged; Odds Ratio; Peptides; Platelet Aggregation Inhibitors; Prognosis; Safety; Survival Rate; Syndrome	1999
Stroke in patients with acute coronary syndromes: incidence and outcomes in the platelet glycoprotein IIb/IIIa in unstable angina. Receptor suppression using integrilin therapy (PURSUIT) trial. The PURSUIT Investigators. Circulation, 1999, May-11, Volume: 99, Issue:18 Topics: Acute Disease; Age Factors; Aged; Angina, Unstable; Aspirin; Brain Damage, Chronic; Cerebral Hemorrhage; Cerebral Infarction; Cerebrovascular Disorders; Comorbidity; Diabetes Mellitus; Double-Blind Method; Drug Therapy, Combination; Electrocardiography; Eptifibatide; Female; Heart Rate; Heparin; Humans; Hyperlipidemias; Hypertension; Incidence; Male; Middle Aged; Obesity; Odds Ratio; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prospective Studies; Recurrence; Risk Factors; Smoking; Treatment Outcome	1999
Glycoprotein IIb/IIIa receptor inhibition in interventional cardiology. Journal of thrombosis and thrombolysis, 1999, Volume: 7, Issue:3 Topics: Abciximab; Administration, Oral; Adult; Aged; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Aspirin; Cardiology; Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Embolism; Eptifibatide; Female; Fibrinolytic Agents; Follow-Up Studies; Forecasting; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Male; Meta-Analysis as Topic; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Peptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prospective Studies; Risk; Stents; Structure-Activity Relationship; Tirofiban; Treatment Outcome; Tyrosine	1999
Safety and efficacy of eptifibatide vs placebo in patients receiving thrombolytic therapy with streptokinase for acute myocardial infarction; a phase II dose escalation, randomized, double-blind study. European heart journal, 2000, Volume: 21, Issue:18 Topics: Adult; Aged; Aspirin; Double-Blind Method; Drug Therapy, Combination; Eptifibatide; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Streptokinase; Thrombolytic Therapy; Treatment Outcome	2000
Use of clopidogrel loading, enoxaparin, and double-bolus eptifibatide in the setting of early percutaneous coronary intervention for acute coronary syndromes. The Journal of invasive cardiology, 2002, Volume: 14, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Artery Disease; Drug Therapy, Combination; Enoxaparin; Eptifibatide; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Peptides; Pilot Projects; Platelet Aggregation Inhibitors; Preoperative Care; Ticlopidine; Treatment Outcome	2002
Activated clotting times in the setting of eptifibatide use during percutaneous coronary intervention. Journal of thrombosis and thrombolysis, 2002, Volume: 13, Issue:3 Topics: Angioplasty, Balloon, Coronary; Aspirin; Blood Coagulation; Blood Coagulation Tests; Clopidogrel; Drug Therapy, Combination; Eptifibatide; Female; Heparin; Humans; Male; Middle Aged; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombophilia; Ticlopidine	2002
Randomized evaluation of the safety and efficacy of enoxaparin versus unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes receiving the glycoprotein IIb/IIIa inhibitor eptifibatide. Circulation, 2003, Jan-21, Volume: 107, Issue:2 Topics: Acute Disease; Aged; Aspirin; Coronary Disease; Electrocardiography; Enoxaparin; Eptifibatide; Female; Hemorrhage; Heparin; Humans; Male; Middle Aged; Monitoring, Physiologic; Myocardial Ischemia; Peptides; Platelet Glycoprotein GPIIb-IIIa Complex; Secondary Prevention; Survival Analysis; Treatment Outcome	2003
Desmopressin antagonizes the in vitro platelet dysfunction induced by GPIIb/IIIa inhibitors and aspirin. Blood, 2003, Dec-15, Volume: 102, Issue:13 Topics: Abciximab; Adenosine Diphosphate; Adult; Antibodies, Monoclonal; Aspirin; Collagen; Cross-Over Studies; Deamino Arginine Vasopressin; Dose-Response Relationship, Drug; Double-Blind Method; Epinephrine; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Male; Peptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Tirofiban; Tyrosine	2003
Evaluating the benefits of glycoprotein IIb/IIIa inhibitors in heart failure at baseline in acute coronary syndromes. American heart journal, 2004, Volume: 147, Issue:1 Topics: Aged; Angina, Unstable; Aspirin; Chi-Square Distribution; Double-Blind Method; Eptifibatide; Female; Heart Failure; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Regression Analysis; Syndrome; Treatment Outcome	2004
Eptifibatide provides additional platelet inhibition in non-ST-elevation myocardial infarction patients already treated with aspirin and clopidogrel. Results of the platelet activity extinction in non-Q-wave myocardial infarction with aspirin, clopidogrel Journal of the American College of Cardiology, 2004, Jan-21, Volume: 43, Issue:2 Topics: Aged; Aspirin; Clopidogrel; Drug Synergism; Drug Therapy, Combination; Enoxaparin; Eptifibatide; Female; Fibrinogen; Fibrinolytic Agents; Humans; Male; Middle Aged; Myocardial Infarction; Peptides; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Ticlopidine; Treatment Outcome	2004
Prospective evaluation of the relationship between platelet-leukocyte conjugate formation and recurrent myocardial ischemia in patients with acute coronary syndromes. Platelets, 2004, Volume: 15, Issue:1 Topics: Adenosine Diphosphate; Adrenergic beta-Antagonists; Aged; Angina, Unstable; Arachidonic Acid; Aspirin; Blood Platelets; C-Reactive Protein; Cell Aggregation; Drug Resistance; Eptifibatide; Female; Heparin; Humans; Leukocytes; Male; Middle Aged; Monocytes; Multivariate Analysis; Myocardial Infarction; Myocardial Ischemia; Neutrophils; Patient Selection; Peptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prospective Studies; Receptors, Thrombin; Recurrence; ROC Curve; Tirofiban; Treatment Outcome; Troponin I; Tyrosine	2004
Association between platelet receptor occupancy after eptifibatide (integrilin) therapy and patency, myocardial perfusion, and ST-segment resolution among patients with ST-segment-elevation myocardial infarction: an INTEGRITI (Integrilin and Tenecteplase Circulation, 2004, Aug-10, Volume: 110, Issue:6 Topics: Adult; Aged; Anticoagulants; Aspirin; Coronary Angiography; Coronary Circulation; Drug Therapy, Combination; Electrocardiography; Eptifibatide; Female; Fibrinolytic Agents; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Partial Thromboplastin Time; Peptides; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Binding; Vascular Patency	2004
Additive effects between platelet concentrates and desmopressin in antagonizing the platelet glycoprotein IIb/IIIa inhibitor eptifibatide. Transfusion, 2005, Volume: 45, Issue:3 Topics: Adult; Anticoagulants; Aspirin; Blood Component Removal; Blood Platelets; Cross-Over Studies; Deamino Arginine Vasopressin; Drug Synergism; Eptifibatide; Hemostatics; Hirudins; Humans; Male; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Platelet Transfusion; Recombinant Proteins	2005
Randomized evaluation of the efficacy of enoxaparin versus unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes receiving the glycoprotein IIb/IIIa inhibitor eptifibatide. Long-term results of the Integrilin American heart journal, 2006, Volume: 151, Issue:2 Topics: Angina, Unstable; Anticoagulants; Aspirin; Enoxaparin; Eptifibatide; Female; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Syndrome	2006
Efficacy and safety of triple antiplatelet therapy with and without concomitant anticoagulation during elective percutaneous coronary intervention (the REMOVE trial). The American journal of cardiology, 2007, Oct-01, Volume: 100, Issue:7 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clopidogrel; Coronary Artery Disease; Drug Therapy, Combination; Eptifibatide; Female; Heparin; Humans; Male; Middle Aged; Peptides; Pilot Projects; Platelet Aggregation Inhibitors; Prospective Studies; Pyridines; Ticlopidine; Treatment Outcome	2007
Comparison of bivalirudin, enoxaparin, and unfractionated heparin in preventing cardiac catheter thrombosis. Results of an in-vitro study. Thrombosis and haemostasis, 2008, Volume: 100, Issue:4 Topics: Anticoagulants; Aspirin; Cardiac Catheterization; Enoxaparin; Eptifibatide; Erythrocytes; Fibrin; Fibrinolytic Agents; Heparin; Hirudins; Humans; In Vitro Techniques; Male; Microscopy, Electron, Scanning; Peptide Fragments; Peptides; Perfusion; Platelet Aggregation Inhibitors; Recombinant Proteins; Thrombosis	2008
Abbreviated infusion of eptifibatide after successful coronary intervention The BRIEF-PCI (Brief Infusion of Eptifibatide Following Percutaneous Coronary Intervention) randomized trial. Journal of the American College of Cardiology, 2009, Mar-10, Volume: 53, Issue:10 Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Combined Modality Therapy; Coronary Disease; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Eptifibatide; Female; Fibrinolytic Agents; Hemorrhage; Humans; Infusions, Intravenous; Male; Middle Aged; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Retreatment; Stents	2009
The effects of aspirin and clopidogrel response on myonecrosis after percutaneous coronary intervention: a BRIEF-PCI (Brief Infusion of Intravenous Eptifibatide Following Successful Percutaneous Coronary Intervention) trial substudy. JACC. Cardiovascular interventions, 2008, Volume: 1, Issue:6 Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Blood Platelets; Clopidogrel; Coronary Artery Disease; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Eptifibatide; Female; Heart Diseases; Hemorrhage; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Necrosis; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prospective Studies; Ticlopidine; Time Factors; Treatment Outcome	2008
Primary percutaneous coronary angioplasty with and without eptifibatide in ST-segment elevation myocardial infarction: a safety and efficacy study of integrilin-facilitated versus primary percutaneous coronary intervention in ST-segment elevation myocardi Circulation. Cardiovascular interventions, 2009, Volume: 2, Issue:4 Topics: Administration, Oral; Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Angiography; Drug Administration Schedule; Drug Therapy, Combination; Eptifibatide; Female; Hemorrhage; Heparin; Humans; Infusions, Intravenous; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Ontario; Peptides; Platelet Aggregation Inhibitors; Prospective Studies; Recurrence; Risk Assessment; Ticlopidine; Time Factors; Treatment Outcome	2009
Eptifibatide infusion versus placebo in high risk patients with non-ST segment elevation acute coronary syndromes managed with urgent coronary artery bypass graft surgery. A prospective multicenter randomized placebo-controlled clinical trial. The Journal of cardiovascular surgery, 2016, Volume: 57, Issue:1 Topics: Acute Coronary Syndrome; Aspirin; Coronary Artery Bypass; Enoxaparin; Eptifibatide; Female; Fibrinolytic Agents; Humans; Infusions, Intravenous; Male; Middle Aged; Peptides; Platelet Aggregation Inhibitors; Prospective Studies; Treatment Outcome	2016
Impact of glycoprotein IIb/IIIa inhibitors on the efficacy and safety of ticagrelor compared with clopidogrel in patients with acute coronary syndromes: Analysis from the Platelet Inhibition and Patient Outcomes (PLATO) Trial. American heart journal, 2016, Volume: 177 Topics: Abciximab; Acute Coronary Syndrome; Adenosine; Aged; Antibodies, Monoclonal; Aspirin; Cardiovascular Diseases; Clopidogrel; Drug Therapy, Combination; Drug-Eluting Stents; Eptifibatide; Female; Graft Occlusion, Vascular; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Myocardial Infarction; Peptides; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Purinergic P2Y Receptor Antagonists; Stroke; Thrombosis; Ticagrelor; Ticlopidine; Tirofiban; Tyrosine	2016

Other Studies

48 other study(ies) available for aspirin and eptifibatide

Article	Year
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Docking based design of diastereoisomeric MTCA as GPIIb/IIIa receptor inhibitor. Bioorganic & medicinal chemistry letters, 2017, 12-01, Volume: 27, Issue:23 Topics: Administration, Oral; Animals; Binding Sites; Blood Platelets; Drug Design; Microscopy, Atomic Force; Molecular Docking Simulation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Structure, Tertiary; Rats; Stereoisomerism; Thermodynamics; Thiazoles; Thrombosis	2017
Antiplatelet therapy in the treatment of coronary heart disease. The Journal of the Arkansas Medical Society, 1994, Volume: 91, Issue:5 Topics: Angioplasty, Balloon, Coronary; Aspirin; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Coronary Disease; Eptifibatide; Humans; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Randomized Controlled Trials as Topic	1994
XIX congress of the European Society of Cardiology August 24-28, 1997, Stockholm, Sweden. Giornale italiano di cardiologia, 1997, Volume: 27, Issue:11 Topics: Amiodarone; Angioplasty, Balloon, Coronary; Anti-Arrhythmia Agents; Anticoagulants; Arteriosclerosis; Aspirin; Cardiology; Coronary Disease; Enoxaparin; Eptifibatide; Europe; Humans; Peptides; Platelet Aggregation Inhibitors; Societies, Medical; Thrombolytic Therapy	1997
Eptifibatide in acute coronary syndromes. The New England journal of medicine, 1999, Jan-07, Volume: 340, Issue:1 Topics: Angina, Unstable; Anticoagulants; Aspirin; Eptifibatide; Heparin; Humans; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex	1999
Super-aspirins in severe angina. Harvard heart letter : from Harvard Medical School, 1998, Volume: 9, Issue:4 Topics: Angina, Unstable; Aspirin; Drug Therapy, Combination; Eptifibatide; Fibrinolytic Agents; Heparin; Humans; Peptides; Platelet Aggregation Inhibitors; Tirofiban; Tyrosine	1998
[Therapy of acute coronary syndrome with glycoprotein IIb/IIIa antagonists]. Medicina clinica, 2000, Oct-07, Volume: 115, Issue:11 Topics: Abciximab; Acute Disease; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Aspirin; Atherectomy; Clinical Trials as Topic; Combined Modality Therapy; Coronary Disease; Eptifibatide; Fibrinolytic Agents; Heparin; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Syndrome; Tirofiban; Tyrosine; United States; United States Food and Drug Administration	2000
Antiplatelet agents in tissue factor-induced blood coagulation. Blood, 2001, Apr-15, Volume: 97, Issue:8 Topics: Abciximab; Adult; Alprostadil; Animals; Antibodies, Monoclonal; Antithrombin III; Aspirin; Blood Coagulation; Dipyridamole; Eptifibatide; Fibrinopeptide A; Humans; Immunoglobulin Fab Fragments; Mice; Osteonectin; Partial Thromboplastin Time; Peptide Hydrolases; Peptides; Plant Proteins; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Proteins; Prothrombin Time; Receptors, Thrombin; Thromboplastin	2001
[Pathophysiology of platelet activation and pharmacology of GPIIb/IIIa inhibitors]. Herz, 2001, Volume: 26 Suppl 1 Topics: Abciximab; Antibodies, Monoclonal; Aspirin; Blood Platelets; Clopidogrel; Eptifibatide; Fibrinolytic Agents; Humans; Immunoglobulin Fab Fragments; Peptides; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Risk Factors; Ticlopidine; Tirofiban; Tyrosine	2001
There is synergism between high-intensity, low-frequency ultrasound and streptokinase but not with eptifibatide, heparin, and aspirin. Differential effects on fresh and aged blood clots. An in vitro study. Thrombosis research, 2001, Aug-15, Volume: 103, Issue:4 Topics: Aspirin; Blood Coagulation; Combined Modality Therapy; Eptifibatide; Fibrinolysis; Fibrinolytic Agents; Heparin; Humans; Kinetics; Peptides; Streptokinase; Ultrasonics	2001
Determination of platelet aggregation inhibition during percutaneous coronary intervention with the platelet function analyzer PFA-100. American heart journal, 2002, Volume: 144, Issue:1 Topics: Abciximab; Aged; Antibodies, Monoclonal; Anticoagulants; Aspirin; Eptifibatide; Female; Heparin; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Peptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Platelet Glycoprotein GPIIb-IIIa Complex; Prospective Studies; Stents	2002
Comparative analysis of various platelet glycoprotein IIb/IIIa antagonists on shear-induced platelet activation and adhesion. The Journal of pharmacology and experimental therapeutics, 2002, Volume: 303, Issue:3 Topics: Abciximab; Alanine; Amidines; Analysis of Variance; Antibodies, Monoclonal; Anticoagulants; Aspirin; Cell Aggregation; Dose-Response Relationship, Drug; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Isoxazoles; Peptides; Platelet Activation; Platelet Adhesiveness; Platelet Glycoprotein GPIIb-IIIa Complex; Pyrrolidines; Rheology; Shear Strength; Temperature; Tirofiban; Tyrosine	2002
Inhibitory effects of glycoprotein IIb/IIIa antagonists and aspirin on the release of soluble CD40 ligand during platelet stimulation. Circulation, 2003, Mar-04, Volume: 107, Issue:8 Topics: Abciximab; Antibodies, Monoclonal; Aspirin; Blood Platelets; CD40 Ligand; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Kinetics; Peptides; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Tirofiban; Tyrosine	2003
[New antiaggregants and their importance for the practitioner]. Therapeutische Umschau. Revue therapeutique, 2003, Volume: 60, Issue:1 Topics: Abciximab; Administration, Oral; Adult; Anesthesia, Spinal; Antibodies, Monoclonal; Aspirin; Cardiovascular Diseases; Clinical Trials as Topic; Clopidogrel; Contraindications; Drug Therapy, Combination; Eptifibatide; Female; Fibrinolytic Agents; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Male; Peptides; Placebos; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pregnancy; Ticlopidine; Tirofiban; Tyrosine	2003
Anticoagulants (thrombin inhibitors) and aspirin synergize with P2Y12 receptor antagonism in thrombosis. Circulation, 2003, Nov-25, Volume: 108, Issue:21 Topics: Amino Acid Chloromethyl Ketones; Animals; Anticoagulants; Antithrombins; Aspirin; Blood Coagulation; Collagen Type III; Diffusion Chambers, Culture; Drug Synergism; Eptifibatide; Factor Xa Inhibitors; Heparin; Heterocyclic Compounds; Humans; In Vitro Techniques; Membrane Proteins; Mice; Mice, Knockout; Microscopy, Video; Peptides; Perfusion; Platelet Aggregation; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Stress, Mechanical; Thiazoles; Thrombin; Thrombosis	2003
Synergism of aspirin and heparin with a low-frequency non-invasive ultrasound system for augmentation of in-vitro clot lysis. Journal of thrombosis and thrombolysis, 2003, Volume: 15, Issue:3 Topics: Adult; Aspirin; Drug Synergism; Drug Therapy, Combination; Eptifibatide; Heparin; Humans; In Vitro Techniques; Peptides; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombolytic Therapy; Tirofiban; Tyrosine; Ultrasonic Therapy	2003
GP IIb/IIIa inhibition with eptifibatide lowers levels of soluble CD40L and RANTES after percutaneous coronary intervention. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2004, Volume: 61, Issue:2 Topics: Abciximab; Aged; Analysis of Variance; Antibodies, Monoclonal; Aspirin; CD40 Ligand; Chemokine CCL5; Coronary Disease; Enzyme-Linked Immunosorbent Assay; Eptifibatide; Female; Heparin; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Peptides; Pilot Projects; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Statistics, Nonparametric; Stents; Treatment Outcome	2004
Percutaneous coronary intervention in a patient with immune thrombocytopenia purpura. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2004, Volume: 61, Issue:3 Topics: Aged; Angioplasty, Balloon; Aspirin; Clopidogrel; Coronary Angiography; Coronary Stenosis; Eptifibatide; Humans; Male; Peptides; Platelet Aggregation Inhibitors; Purpura, Thrombocytopenic, Idiopathic; Stents; Ticlopidine	2004
[Efficacy and safety of treatment of acute ischemic stroke with glycoprotein IIb/IIIa receptor blocker in routine clinical practice]. Deutsche medizinische Wochenschrift (1946), 2004, Mar-19, Volume: 129, Issue:12 Topics: Adult; Aged; Anticoagulants; Aspirin; Brain; Brain Ischemia; Carotid Arteries; Clopidogrel; Drug Therapy, Combination; Echocardiography, Transesophageal; Eptifibatide; Female; Heparin; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Retrospective Studies; Stroke; Ticlopidine; Tirofiban; Tomography, X-Ray Computed; Tyrosine; Ultrasonography, Doppler	2004
Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction. Circulation, 2004, Jun-29, Volume: 109, Issue:25 Topics: Adenosine Diphosphate; Aged; Aspirin; Biotransformation; Clopidogrel; Combined Modality Therapy; Coronary Artery Disease; Coronary Restenosis; Coronary Thrombosis; Drug Resistance; Drug Therapy, Combination; Epinephrine; Eptifibatide; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Peptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Prodrugs; Prospective Studies; Purinergic P2 Receptor Antagonists; Recurrence; Risk; Smoking; Stents; Ticlopidine; Treatment Outcome	2004
Clopidogrel resistance: a new chapter in a fast-moving story. Circulation, 2004, Jun-29, Volume: 109, Issue:25 Topics: Angioplasty; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clopidogrel; Coronary Disease; Dose-Response Relationship, Drug; Drug Resistance; Drug Therapy, Combination; Eptifibatide; Heparin; Humans; Peptides; Platelet Aggregation Inhibitors; Stents; Thromboxane A2; Ticlopidine; Treatment Outcome	2004
Platelet function predicts myocardial damage in patients with acute myocardial infarction. Circulation, 2004, Sep-14, Volume: 110, Issue:11 Topics: Abciximab; Adenosine Diphosphate; Aged; Antibodies, Monoclonal; Anticoagulants; Aspirin; Cardiovascular Agents; Clopidogrel; Collagen; Comorbidity; Eptifibatide; Female; Humans; Immunoglobulin Fab Fragments; Leukocyte Count; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Myocardium; Necrosis; Peptides; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Predictive Value of Tests; Prospective Studies; Ticlopidine; Tirofiban; Tyrosine; von Willebrand Factor	2004
Antiplatelet therapy in non-ST-segment elevation acute coronary syndromes. JAMA, 2004, Oct-20, Volume: 292, Issue:15 Topics: Adrenergic beta-Antagonists; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Artery Bypass; Coronary Artery Disease; Coronary Thrombosis; Drug Therapy, Combination; Electrocardiography; Eptifibatide; Heparin; Humans; Male; Middle Aged; Myocardial Ischemia; Nitroglycerin; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Risk Assessment; Stents; Ticlopidine; Vasodilator Agents	2004
A case of life-saving pharmacologic and mechanical coronary dethrombosis. Italian heart journal : official journal of the Italian Federation of Cardiology, 2004, Volume: 5, Issue:11 Topics: Angioplasty, Balloon; Aspirin; Combined Modality Therapy; Coronary Angiography; Coronary Thrombosis; Electrocardiography; Eptifibatide; Fibrinolytic Agents; Heparin; Humans; Intra-Aortic Balloon Pumping; Male; Middle Aged; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Thrombectomy; Ticlopidine; Tissue Plasminogen Activator	2004
Elective percutaneous coronary intervention using broad-spectrum antiplatelet therapy (eptifibatide, clopidogrel, and aspirin) alone, without scheduled unfractionated heparin or other antithrombin therapy. American heart journal, 2005, Volume: 149, Issue:1 Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Disease; Drug Therapy, Combination; Eptifibatide; Female; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Retrospective Studies; Stents; Ticlopidine	2005
Dual antiplatelet therapy for coronary stenting: a clear path for a research agenda. Circulation, 2005, Mar-08, Volume: 111, Issue:9 Topics: Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Stenosis; Coronary Thrombosis; Drug Administration Schedule; Drug Therapy, Combination; Eptifibatide; Hemorrhage; Length of Stay; Membrane Proteins; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Premedication; Purinergic P2 Receptor Antagonists; Randomized Controlled Trials as Topic; Receptors, Purinergic P2Y12; Risk Factors; Stents; Thrombophilia; Ticlopidine	2005
Investigation of the PADA as a method for monitoring GPIIb/IIIa inhibitors and other antiplatelet agents. Seminars in thrombosis and hemostasis, 2005, Volume: 31, Issue:4 Topics: Abciximab; Adenosine Monophosphate; Antibodies, Monoclonal; Anticoagulants; Aspirin; Clopidogrel; Dose-Response Relationship, Drug; Drug Monitoring; Eptifibatide; Hirudins; Humans; Immunoglobulin Fab Fragments; Peptides; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Platelet Function Tests; Platelet Glycoprotein GPIIb-IIIa Complex; Sensitivity and Specificity; Ticlopidine	2005
In vitro effect of the potent poly(ADP-ribose) polymerase (PARP) inhibitor INO-1001 alone and in combination with aspirin, eptifibatide, tirofiban, enoxaparin or alteplase on haemostatic parameters. Life sciences, 2006, Jun-20, Volume: 79, Issue:4 Topics: Aspirin; Blood Coagulation; Blood Platelets; Dose-Response Relationship, Drug; Drug Combinations; Enzyme Inhibitors; Eptifibatide; Factor Xa Inhibitors; Female; Heparin; Humans; Indoles; Male; Partial Thromboplastin Time; Peptides; Platelet Aggregation Inhibitors; Poly(ADP-ribose) Polymerase Inhibitors; Tirofiban; Tissue Plasminogen Activator; Tyrosine	2006
Role of antiplatelets in carotid artery stenting. Stroke, 2007, Volume: 38, Issue:1 Topics: Angioplasty, Balloon; Aspirin; Carotid Stenosis; Clinical Trials as Topic; Clopidogrel; Dipyridamole; Eptifibatide; Humans; Peptides; Platelet Aggregation Inhibitors; Stents; Stroke; Ticlopidine	2007
Focus on adjunctive pharmacotherapy to improve outcomes of percutaneous coronary intervention. The Journal of invasive cardiology, 2009, Volume: 21, Issue:3 Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Aspirin; Chemotherapy, Adjuvant; Clopidogrel; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Therapy; Electrocardiography; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Ticlopidine; Treatment Outcome	2009
Spontaneous coronary artery dissection and severe hypothyroidism. The Journal of invasive cardiology, 2009, Volume: 21, Issue:4 Topics: Acute Coronary Syndrome; Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Aspirin; Clopidogrel; Coronary Artery Disease; Coronary Vessels; Eptifibatide; Fatal Outcome; Female; Humans; Hypothyroidism; Neck Pain; Peptides; Platelet Aggregation Inhibitors; Ticlopidine	2009
Regulation of CD40L (CD154) and CD62P (p-selectin) surface expression upon GPIIb-IIIa blockade of platelets from stable coronary artery disease patients. Thrombosis research, 2010, Volume: 125, Issue:1 Topics: Aspirin; Blood Platelets; CD40 Ligand; Coronary Disease; Dose-Response Relationship, Drug; Eptifibatide; Humans; P-Selectin; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex	2010
Frequency and outcomes of provisional glycoprotein IIb/IIIa blockade in patients receiving bivalirudin during percutaneous coronary intervention. The Journal of invasive cardiology, 2009, Volume: 21, Issue:6 Topics: Abciximab; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Aspirin; Clopidogrel; Drug Therapy, Combination; Embolism; Eptifibatide; Female; Follow-Up Studies; Hirudins; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Peptide Fragments; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Recombinant Proteins; Registries; Regression Analysis; Retrospective Studies; Thrombosis; Ticlopidine; Treatment Outcome	2009
Effective management of acute coronary thrombosis in a young woman with lupus using aggressive medical therapy. Cardiology, 2011, Volume: 118, Issue:1 Topics: Adult; Aspirin; Clopidogrel; Coronary Thrombosis; Eptifibatide; Female; Fibrinolytic Agents; Heparin; Humans; Lupus Erythematosus, Systemic; Peptides; Platelet Aggregation Inhibitors; Ticlopidine	2011
Left main stent thrombosis complicated by eptifibatide-induced acute thrombocytopenia. Texas Heart Institute journal, 2011, Volume: 38, Issue:2 Topics: Acute Disease; Angioplasty, Balloon, Coronary; Aspirin; Cardiac Catheterization; Clopidogrel; Coronary Angiography; Coronary Artery Disease; Drug Therapy, Combination; Electrocardiography; Eptifibatide; Heparin; Humans; Male; Middle Aged; Peptides; Platelet Aggregation Inhibitors; Platelet Count; Stents; Thrombectomy; Thrombocytopenia; Thrombosis; Ticlopidine; Treatment Outcome	2011
A case of acute stent thrombosis during treatment with the thrombopoietin receptor agonist peptide--romiplostim. Heart, lung & circulation, 2012, Volume: 21, Issue:3 Topics: Acute Disease; Aspirin; Chest Pain; Clopidogrel; Eptifibatide; Female; Humans; Middle Aged; Peptides; Piperazines; Platelet Aggregation Inhibitors; Platelet Count; Prasugrel Hydrochloride; Purpura, Thrombocytopenic, Idiopathic; Receptors, Thrombopoietin; Risk Factors; Stents; Thiophenes; Thrombosis; Ticlopidine; Ultrasonography, Interventional	2012
[Diagnostic laparoscopy under dual antiplatelet therapy with clopidogrel and aspirin]. Medizinische Klinik, Intensivmedizin und Notfallmedizin, 2011, Volume: 106, Issue:1 Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Diagnosis, Differential; Drug Substitution; Drug Therapy, Combination; Drug-Eluting Stents; Eptifibatide; Female; Humans; Laparoscopy; Multiple Myeloma; Peptides; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Risk Factors; Thrombosis; Ticlopidine	2011
Peripartum management of dual antiplatelet therapy and neuraxial labor analgesia after bare metal stent insertion for acute myocardial infarction. Anesthesia and analgesia, 2012, Volume: 115, Issue:3 Topics: Adult; Analgesia, Obstetrical; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Eptifibatide; Female; Humans; Metals; Myocardial Infarction; Nerve Block; Peptides; Peripartum Period; Platelet Aggregation Inhibitors; Pregnancy; Pregnancy Complications; Stents; Ticlopidine	2012
Safety of "bridging" with eptifibatide for patients with coronary stents before cardiac and non-cardiac surgery. The American journal of cardiology, 2012, Aug-15, Volume: 110, Issue:4 Topics: Aged; Aspirin; Blood Transfusion; Cardiovascular Surgical Procedures; Case-Control Studies; Coronary Thrombosis; Drug Therapy, Combination; Drug-Eluting Stents; Eptifibatide; Female; Heart Diseases; Heparin; Humans; Male; Middle Aged; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Postoperative Hemorrhage; Retrospective Studies	2012
A case of in-stent thrombosis in a patient with drug eluting stents during perioperative management with glycoprotein IIb/IIIa inhibitors. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2013, Dec-01, Volume: 82, Issue:7 Topics: Aged; Aspirin; Clopidogrel; Coronary Angiography; Coronary Artery Disease; Coronary Thrombosis; Drug Substitution; Drug Therapy, Combination; Drug-Eluting Stents; Eptifibatide; Female; Humans; Neurosurgical Procedures; Peptides; Percutaneous Coronary Intervention; Perioperative Period; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Ticlopidine; Time Factors; Treatment Outcome; Ultrasonography, Interventional	2013
Loading conditions influence reliability of the echocardiographic ramp test in continuous-flow left ventricular assist devices. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2013, Volume: 32, Issue:11 Topics: Aged; Aspirin; Drug Therapy, Combination; Echocardiography; Eptifibatide; Heart-Assist Devices; Hemodynamics; Heparin; Humans; Male; Milrinone; Peptides; Reproducibility of Results; Thromboembolism; Ventricular Dysfunction, Left	2013
Perioperative management of antiplatelet therapy in patients with coronary stents undergoing cardiac and non-cardiac surgery: a consensus document from Italian cardiological, surgical and anaesthesiological societies. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2014, Volume: 10, Issue:1 Topics: Anesthesiology; Aspirin; Cardiac Surgical Procedures; Cardiology; Clopidogrel; Eptifibatide; Hemorrhage; Humans; Italy; Myocardial Ischemia; Peptides; Perioperative Care; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Risk Assessment; Societies, Medical; Stents; Surgical Procedures, Operative; Thoracic Surgery; Ticlopidine; Tirofiban; Tyrosine	2014
Intravenous Antiplatelet Therapy Bridging in Patients Undergoing Cardiac or Non-Cardiac Surgery Following Percutaneous Coronary Intervention. Cardiovascular revascularization medicine : including molecular interventions, 2019, Volume: 20, Issue:9 Topics: Adenosine Monophosphate; Administration, Intravenous; Aged; Aspirin; Cardiac Surgical Procedures; Clopidogrel; Coronary Artery Disease; Coronary Thrombosis; Drug Administration Schedule; Drug Substitution; Drug Therapy, Combination; Drug-Eluting Stents; Eptifibatide; Female; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Perioperative Care; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors; Time Factors; Tirofiban; Treatment Outcome	2019
Thrombocytopenia and Thromboses in Myocardial Infarction Associated with Eptifibatide-Dependent Activating Antiplatelet Antibodies. Thrombosis and haemostasis, 2020, Volume: 120, Issue:7 Topics: Antigens, Human Platelet; Arginine; Aspirin; Autoantibodies; Combined Modality Therapy; Coronary Thrombosis; Drug Substitution; Drug Therapy, Combination; Eptifibatide; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Pipecolic Acids; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Platelet Transfusion; Purpura, Thrombocytopenic, Idiopathic; Shock, Cardiogenic; ST Elevation Myocardial Infarction; Stents; Sulfonamides; Thrombectomy; Thrombolytic Therapy; Thrombosis; Ticagrelor; Warfarin	2020
Adjunctive treatment with low dose intra-arterial eptifibatide and intravenous aspirin during carotid stenting: A case series. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2021, Volume: 84 Topics: Aged; Aspirin; Carotid Stenosis; Clopidogrel; Endovascular Procedures; Eptifibatide; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Retrospective Studies; Stents; Stroke; Treatment Outcome	2021
Mechanically Triggered Hybridization Chain Reaction. Angewandte Chemie (International ed. in English), 2021, 09-01, Volume: 60, Issue:36 Topics: Aspirin; Eptifibatide; Humans; Nucleic Acid Hybridization	2021
Eptifibatide-induced acute profound thrombocytopenia: A case report. Medicine, 2022, Oct-21, Volume: 101, Issue:42 Topics: Acute Coronary Syndrome; Aspirin; Clopidogrel; Eptifibatide; Glycoproteins; Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Thrombocytopenia	2022
Studying the efficacy of antiplatelet drugs on atherosclerosis by optofluidic imaging on a chip. Lab on a chip, 2023, 01-31, Volume: 23, Issue:3 Topics: Aspirin; Atherosclerosis; Blood Platelets; Constriction, Pathologic; Eptifibatide; Humans; Lab-On-A-Chip Devices; Platelet Aggregation Inhibitors; Thrombosis	2023